T1	B-Protein	B-Protein	0	1	c	c	O	SYM	B-protein	3	NMOD	B-protein
T1	I-Protein	I-Protein	1	2	-	-	O	:	I-protein	3	NMOD	I-protein
T1	I-Protein	I-Protein	2	5	Rel	Rel	B-NP	NN	I-protein	4	SUB	I-protein
O	O	O	6	8	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	9	10	a	a	B-NP	DT	O	6	NMOD	O
O	O	O	11	17	target	target	I-NP	NN	O	4	PRD	O
O	O	O	18	20	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	21	35	pentoxifylline	pentoxifylline	B-NP	NN	O	7	PMOD	O
O	O	O	35	36	-	-	O	HYPH	O	8	NMOD	O
O	O	O	36	44	mediated	mediate	B-NP	VBN	O	11	NMOD	O
O	O	O	45	55	inhibition	inhibition	I-NP	NN	O	9	OBJ	O
O	O	O	56	58	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	59	60	T	T	B-NP	NN	B-cell_type	15	NMOD	B-cell_type
O	O	O	61	71	lymphocyte	lymphocyte	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	O	72	82	activation	activation	I-NP	NN	O	12	PMOD	O
O	O	O	82	83	.	.	O	.	O	4	P	O

O	O	O	85	88	The	The	B-NP	DT	O	4	NMOD	O
O	O	O	89	97	possible	possible	I-NP	JJ	O	3	AMOD	O
O	O	O	98	106	clinical	clinical	I-NP	JJ	O	4	NMOD	O
O	O	O	107	110	use	use	I-NP	NN	O	25	SUB	O
O	O	O	111	113	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	114	117	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	118	124	methyl	methyl	I-NP	NN	O	8	NMOD	O
O	O	O	125	133	xanthine	xanthine	I-NP	NN	O	24	NMOD	O
O	O	O	134	144	derivative	derivative	I-NP	NN	O	8	NMOD	O
O	O	O	144	145	,	,	O	,	O	24	P	O
O	O	O	146	160	pentoxifylline	pentoxifylline	B-NP	NN	O	24	NMOD	O
O	O	O	161	162	(	(	O	(	O	14	DEP	O
O	O	O	162	164	PF	PF	B-NP	NN	O	14	DEP	O
O	O	O	164	165	)	)	O	)	O	11	NMOD	O
O	O	O	165	166	,	,	O	,	O	11	P	O
O	O	O	167	170	for	for	B-PP	IN	O	11	NMOD	O
O	O	O	171	174	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	175	184	treatment	treatment	I-NP	NN	O	16	PMOD	O
O	O	O	185	187	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	188	189	T	T	B-NP	NN	B-cell_type	21	NMOD	B-cell_type
O	O	O	190	194	cell	cell	I-NP	NN	I-cell_type	19	PMOD	I-cell_type
O	O	O	194	195	-	-	B-NP	HYPH	O	24	NMOD	O
O	O	O	195	204	dependent	dependent	I-NP	JJ	O	24	NMOD	O
O	O	O	205	213	diseases	disease	I-NP	NNS	O	5	PMOD	O
O	O	O	214	216	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	217	222	being	be	I-VP	VBG	O	25	VC	O
O	O	O	223	228	noted	note	I-VP	VBN	O	26	VC	O
O	O	O	229	233	with	with	B-PP	IN	O	27	VMOD	O
O	O	O	234	244	increasing	increase	B-NP	VBG	O	30	NMOD	O
O	O	O	245	253	interest	interest	I-NP	NN	O	28	PMOD	O
O	O	O	253	254	.	.	O	.	O	25	P	O

O	O	O	255	257	In	In	B-PP	IN	O	6	VMOD	O
O	O	O	258	262	this	this	B-NP	DT	O	3	NMOD	O
O	O	O	263	268	paper	paper	I-NP	NN	O	1	PMOD	O
O	O	O	268	269	,	,	O	,	O	6	P	O
O	O	O	270	272	we	we	B-NP	PRP	O	6	SUB	O
O	O	O	273	280	studied	study	B-VP	VBD	O	0	ROOT	O
O	O	O	281	284	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	285	294	molecular	molecular	I-NP	JJ	O	9	NMOD	O
O	O	O	295	307	consequences	consequence	I-NP	NNS	O	6	OBJ	O
O	O	O	308	310	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	311	313	PF	PF	B-NP	NN	O	12	NMOD	O
O	O	O	314	323	treatment	treatment	I-NP	NN	O	10	PMOD	O
O	O	O	324	330	during	during	B-PP	IN	O	6	VMOD	O
O	O	O	331	341	lymphocyte	lymphocyte	B-NP	NN	O	15	NMOD	O
O	O	O	342	352	activation	activation	I-NP	NN	O	13	PMOD	O
O	O	O	352	353	.	.	O	.	O	6	P	O

O	O	O	354	356	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	357	362	found	find	B-VP	VBD	O	0	ROOT	O
O	O	O	363	367	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	368	370	in	in	B-PP	IN	O	17	VMOD	O
O	O	O	371	372	T	T	B-NP	NN	B-cell_type	6	NMOD	B-cell_type
O	O	O	373	378	cells	cell	I-NP	NNS	I-cell_type	4	PMOD	I-cell_type
O	O	O	378	379	,	,	O	,	O	17	P	O
O	O	O	380	384	anti	anti	O	AFX	O	16	NMOD	O
O	O	O	384	385	-	-	B-NP	HYPH	O	16	NMOD	O
T9	B-Entity	B-Entity	385	388	CD3	CD3	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	388	389	-	-	O	HYPH	O	10	P	O
O	O	O	389	396	induced	induce	B-NP	VBN	O	16	NMOD	O
T2	B-Protein	B-Protein	397	398	c	c	I-NP	NN	B-protein	16	NMOD	B-protein
T2	I-Protein	I-Protein	398	399	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T2	I-Protein	I-Protein	399	402	Rel	Rel	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	O	403	413	expression	expression	I-NP	NN	O	17	SUB	O
O	O	O	414	417	was	be	B-VP	VBD	O	3	SBAR	O
O	O	O	418	425	blocked	block	I-VP	VBN	O	17	VC	O
O	O	O	426	428	by	by	B-PP	IN	O	18	VMOD	O
O	O	O	429	431	PF	PF	B-NP	NN	O	19	PMOD	O
O	O	O	431	432	,	,	O	,	O	17	P	O
O	O	O	433	440	whereas	whereas	O	IN	O	17	VMOD	O
O	O	O	441	444	the	the	B-NP	DT	O	24	NMOD	O
O	O	O	445	454	induction	induction	I-NP	NN	O	32	SUB	O
O	O	O	455	457	of	of	B-PP	IN	O	24	NMOD	O
O	O	O	458	463	other	other	B-NP	JJ	O	31	NMOD	O
T10	B-Entity	B-Entity	464	466	NF	NF	I-NP	NN	B-protein	31	NMOD	B-protein
T10	I-Entity	I-Entity	466	467	-	-	I-NP	HYPH	I-protein	31	NMOD	I-protein
T10	I-Entity	I-Entity	467	473	kappaB	kappaB	I-NP	NN	I-protein	31	NMOD	I-protein
O	O	O	474	480	family	family	I-NP	NN	I-protein	31	NMOD	I-protein
O	O	O	481	488	members	member	I-NP	NNS	I-protein	25	PMOD	I-protein
O	O	O	489	492	was	be	B-VP	VBD	O	22	SBAR	O
O	O	O	493	496	not	not	I-VP	RB	O	32	VMOD	O
O	O	O	497	510	significantly	significantly	I-VP	RB	O	32	VMOD	O
O	O	O	511	519	affected	affect	I-VP	VBN	O	32	VC	O
O	O	O	519	520	.	.	O	.	O	2	P	O

O	O	O	521	528	However	However	B-ADVP	RB	O	21	VMOD	O
O	O	O	528	529	,	,	O	,	O	21	P	O
O	O	O	530	539	induction	induction	B-NP	NN	O	21	SUB	O
O	O	O	540	542	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	543	545	NF	NF	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	545	546	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
O	O	O	546	548	AT	AT	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	O	548	549	,	,	O	,	O	7	P	O
O	O	O	550	555	which	which	B-NP	WDT	O	7	NMOD	O
O	O	O	556	559	has	have	B-VP	VBZ	O	9	SBAR	O
O	O	O	560	563	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	564	568	same	same	I-NP	JJ	O	14	NMOD	O
O	O	O	569	578	signaling	signaling	I-NP	NN	O	14	NMOD	O
O	O	O	579	591	requirements	requirement	I-NP	NNS	O	10	OBJ	O
O	O	O	592	594	as	as	B-PP	IN	O	14	NMOD	O
T3	B-Protein	B-Protein	595	596	c	c	B-NP	NN	B-protein	19	NMOD	B-protein
T3	I-Protein	I-Protein	596	597	-	-	I-NP	HYPH	I-protein	19	NMOD	I-protein
T3	I-Protein	I-Protein	597	600	Rel	Rel	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	O	601	610	induction	induction	I-NP	NN	O	15	PMOD	O
O	O	O	610	611	,	,	O	,	O	3	P	O
O	O	O	612	615	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	616	619	not	not	I-VP	RB	O	21	VMOD	O
O	O	O	620	629	inhibited	inhibit	I-VP	VBN	O	21	VC	O
O	O	O	630	632	by	by	B-PP	IN	O	23	VMOD	O
O	O	O	633	635	PF	PF	B-NP	NN	O	24	PMOD	O
O	O	O	635	636	.	.	O	.	O	21	P	O

O	O	O	637	642	Among	Among	B-PP	IN	O	15	VMOD	O
O	O	O	643	648	genes	gene	B-NP	NNS	O	1	PMOD	O
O	O	O	649	653	that	that	B-NP	WDT	O	2	NMOD	O
O	O	O	654	661	respond	respond	B-VP	VBP	O	3	SBAR	O
O	O	O	662	664	to	to	B-PP	TO	O	4	VMOD	O
O	O	O	665	670	these	these	B-NP	DT	O	8	NMOD	O
O	O	O	671	684	transcription	transcription	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	685	692	factors	factor	I-NP	NNS	I-protein	5	PMOD	I-protein
O	O	O	692	693	,	,	O	,	O	15	P	O
T4	B-Protein	B-Protein	694	696	IL	IL	B-NP	NN	B-RNA	13	NMOD	B-RNA
T4	I-Protein	I-Protein	696	697	-	-	B-NP	HYPH	I-RNA	10	NMOD	I-RNA
T4	I-Protein	I-Protein	697	698	2	2	I-NP	CD	I-RNA	13	NMOD	I-RNA
O	O	O	699	703	mRNA	mRNA	I-NP	NN	I-RNA	14	NMOD	I-RNA
O	O	O	704	713	induction	induction	I-NP	NN	O	15	SUB	O
O	O	O	714	717	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	718	728	suppressed	suppress	I-VP	VBN	O	15	VC	O
O	O	O	729	731	by	by	B-PP	IN	O	16	VMOD	O
O	O	O	732	734	PF	PF	B-NP	NN	O	17	PMOD	O
O	O	O	734	735	,	,	O	,	O	15	P	O
O	O	O	736	743	whereas	whereas	O	IN	O	15	VMOD	O
T5	B-Protein	B-Protein	744	746	IL	IL	O	NN	B-RNA	29	NMOD	B-RNA
T5	I-Protein	I-Protein	746	747	-	-	O	HYPH	I-RNA	29	NMOD	I-RNA
T5	I-Protein	I-Protein	747	749	2R	2R	B-NP	NN	I-RNA	28	NMOD	I-RNA
T5	I-Protein	I-Protein	749	750	(	(	O	(	I-RNA	28	NMOD	I-RNA
T5	I-Protein	I-Protein	750	755	alpha	alpha	B-NP	NN	I-RNA	28	NMOD	I-RNA
T5	I-Protein	I-Protein	755	756	)	)	O	)	I-RNA	28	NMOD	I-RNA
T5	I-Protein	I-Protein	757	762	chain	chain	B-NP	NN	I-RNA	28	NMOD	I-RNA
O	O	O	763	767	mRNA	mRNA	I-NP	NN	I-RNA	29	NMOD	I-RNA
O	O	O	768	777	induction	induction	I-NP	NN	O	30	SUB	O
O	O	O	778	781	was	be	B-VP	VBD	O	20	SBAR	O
O	O	O	782	785	not	not	I-VP	RB	O	30	VMOD	O
O	O	O	786	794	affected	affect	I-VP	VBN	O	30	VC	O
O	O	O	794	795	.	.	O	.	O	15	P	O

O	O	O	796	801	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	802	814	observations	observation	I-NP	NNS	O	6	NMOD	O
O	O	O	815	825	implicated	implicate	B-NP	VBN	O	6	NMOD	O
T6	B-Protein	B-Protein	826	827	c	c	I-NP	NN	B-protein	6	NMOD	B-protein
T6	I-Protein	I-Protein	827	828	-	-	O	:	I-protein	6	P	I-protein
T6	I-Protein	I-Protein	828	831	Rel	Rel	B-NP	NN	I-protein	0	ROOT	I-protein
O	O	O	832	834	as	as	B-PP	IN	O	6	NMOD	O
O	O	O	835	837	an	an	B-NP	DT	O	13	NMOD	O
T7	B-Protein	B-Protein	838	840	IL	IL	I-NP	NN	B-protein	13	NMOD	B-protein
T7	I-Protein	I-Protein	840	841	-	-	I-NP	HYPH	I-protein	13	NMOD	I-protein
T7	I-Protein	I-Protein	841	842	2	2	I-NP	CD	I-protein	13	NMOD	I-protein
T11	B-Entity	B-Entity	843	851	promoter	promoter	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	852	858	factor	factor	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	O	858	859	,	,	O	,	O	13	P	O
O	O	O	860	863	for	for	B-PP	IN	O	13	NMOD	O
O	O	O	864	869	which	which	B-NP	WDT	O	15	PMOD	O
O	O	O	870	882	experimental	experimental	B-NP	JJ	O	18	NMOD	O
O	O	O	883	890	support	support	I-NP	NN	O	19	SUB	O
O	O	O	891	894	was	be	B-VP	VBD	O	15	SBAR	O
O	O	O	895	903	obtained	obtain	I-VP	VBN	O	19	VC	O
O	O	O	904	908	from	from	B-PP	IN	O	20	VMOD	O
O	O	O	909	918	transient	transient	B-NP	JJ	O	24	NMOD	O
O	O	O	919	931	transfection	transfection	I-NP	NN	O	24	NMOD	O
O	O	O	932	943	experiments	experiment	I-NP	NNS	O	21	PMOD	O
O	O	O	943	944	.	.	O	.	O	6	P	O

O	O	O	945	947	In	In	B-PP	IN	O	14	VMOD	O
O	O	O	948	956	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	O	957	961	with	with	B-PP	IN	O	2	NMOD	O
O	O	O	962	965	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	966	977	observation	observation	I-NP	NN	O	13	NMOD	O
O	O	O	978	980	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	981	982	T	T	B-NP	NN	B-cell_type	8	NMOD	B-cell_type
O	O	O	983	988	cells	cell	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	O	988	989	,	,	O	,	O	13	P	O
T8	B-Protein	B-Protein	990	991	c	c	B-NP	NN	B-protein	13	NMOD	B-protein
T8	I-Protein	I-Protein	991	992	-	-	I-NP	HYPH	I-protein	13	NMOD	I-protein
T8	I-Protein	I-Protein	992	995	Rel	Rel	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	996	1005	induction	induction	I-NP	NN	O	3	PMOD	O
O	O	O	1006	1009	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1010	1013	not	not	I-VP	RB	O	14	VMOD	O
O	O	O	1014	1021	blocked	block	I-VP	VBN	O	14	VC	O
O	O	O	1022	1024	by	by	B-PP	IN	O	16	VMOD	O
O	O	O	1025	1027	PF	PF	B-NP	NN	O	17	PMOD	O
O	O	O	1028	1030	in	in	B-PP	IN	O	16	VMOD	O
O	O	O	1031	1032	B	B	B-NP	NN	B-cell_type	21	NMOD	B-cell_type
O	O	O	1033	1038	cells	cell	I-NP	NNS	I-cell_type	19	PMOD	I-cell_type
O	O	O	1038	1039	.	.	O	.	O	14	P	O

O	O	O	1040	1043	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	1044	1051	greater	great	I-NP	JJR	O	3	NMOD	O
O	O	O	1052	1063	selectivity	selectivity	I-NP	NN	O	18	SUB	O
O	O	O	1064	1066	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	1067	1069	PF	PF	B-NP	NN	O	4	PMOD	O
O	O	O	1069	1070	,	,	O	,	O	3	P	O
O	O	O	1071	1079	compared	compare	B-PP	VBN	O	3	NMOD	O
O	O	O	1080	1084	with	with	B-PP	IN	O	7	PMOD	O
O	O	O	1085	1090	FK506	FK506	B-NP	NN	O	8	PMOD	O
O	O	O	1090	1091	,	,	O	,	O	3	P	O
O	O	O	1092	1094	at	at	B-PP	IN	O	3	NMOD	O
O	O	O	1095	1099	both	both	O	CC	O	17	NMOD	O
O	O	O	1100	1103	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	1104	1113	molecular	molecular	I-NP	JJ	O	17	NMOD	O
O	O	O	1114	1117	and	and	I-NP	CC	O	17	NMOD	O
O	O	O	1118	1126	cellular	cellular	I-NP	JJ	O	17	NMOD	O
O	O	O	1127	1133	levels	level	I-NP	NNS	O	11	PMOD	O
O	O	O	1134	1137	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	1138	1143	prove	prove	I-VP	VB	O	18	VC	O
O	O	O	1144	1156	advantageous	advantageous	B-ADJP	JJ	O	19	PRD	O
O	O	O	1157	1159	in	in	B-PP	IN	O	20	AMOD	O
O	O	O	1160	1172	manipulating	manipulate	B-VP	VBG	O	21	PMOD	O
O	O	O	1173	1174	T	T	B-NP	NN	O	25	NMOD	O
O	O	O	1175	1179	cell	cell	I-NP	NN	O	25	NMOD	O
O	O	O	1180	1189	responses	response	I-NP	NNS	O	22	OBJ	O
O	O	O	1190	1192	in	in	B-ADVP	FW	O	25	NMOD	O
O	O	O	1193	1197	vivo	vivo	I-ADVP	FW	O	26	AMOD	O
O	O	O	1197	1198	.	.	O	.	O	18	P	O
